Diaceutics 

GBX161.5
5
+GBX7+4.53% Today

Statistics

Day High
161.5
Day Low
152
52W High
176.25
52W Low
108
Volume
86,076.55
Avg. Volume
-
Mkt Cap
136.97M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24MarExpected
Q1 2024
Q2 2024
Q4 2024
Q1 2025
Q2 2025
Q4 2025
Q4 2025
-3.65
-0.93
1.78
4.5
Expected EPS
3.0596555584000003
Actual EPS
N/A

Financials

-5.3%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
6.43BRevenue
-340.6MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DXRX.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Show more...
CEO
Mr. Peter Keeling
Employees
213
Country
GB
ISIN
GB00BJQTGV64

Listings

0 Comments

Share your thoughts

FAQ

What is Diaceutics stock price today?
The current price of DXRX.LSE is GBX161.5 GBX — it has increased by +4.53% in the past 24 hours. Watch Diaceutics stock price performance more closely on the chart.
What is Diaceutics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Diaceutics stocks are traded under the ticker DXRX.LSE.
Is Diaceutics stock price growing?
DXRX.LSE stock has risen by +7.31% compared to the previous week, the month change is a +10.57% rise, over the last year Diaceutics has showed a +49.54% increase.
What is Diaceutics market cap?
Today Diaceutics has the market capitalization of 136.97M
When is the next Diaceutics earnings date?
Diaceutics is going to release the next earnings report on September 29, 2026.
What is Diaceutics revenue for the last year?
Diaceutics revenue for the last year amounts to 6.43B GBX.
What is Diaceutics net income for the last year?
DXRX.LSE net income for the last year is -340.6M GBX.
How many employees does Diaceutics have?
As of April 07, 2026, the company has 213 employees.
In which sector is Diaceutics located?
Diaceutics operates in the Health Care sector.
When did Diaceutics complete a stock split?
Diaceutics has not had any recent stock splits.
Where is Diaceutics headquartered?
Diaceutics is headquartered in Belfast, GB.